Deutsch English Français

Contact

EP3856156

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3856156

EP3856156 - 5-HT7 ANTAGONIST FOR THE TREATMENT OF DEMENTIA-ASSOCIATED TAUOPATHIES [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 22.03.2024 Database last updated on 03.10.2024
Former	Request for examination was made Status updated on 02.07.2021
Former	The international publication has been made Status updated on 05.04.2020
Former	unknown Status updated on 30.10.2019
Most recent event Tooltip	27.09.2024	New entry: Renewal fee paid
Applicant(s)	For all designated states Medizinische Hochschule Hannover (MHH) Carl-Neuberg-Strasse 1 30625 Hannover / DE
	For all designated states Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) Venusberg-Campus 1, Gebäude 99 53127 Bonn / DE
	[2021/31]
Inventor(s)	01 / PONIMASKIN, Evgeni Am Friedenstal 11A 30627 Hannover / DE
	02 / ROEHRS, Kian-Fritz Drei Eichen 19 27283 Verden/Aller / DE
	03 / BUTZLAFF, Malte Benrode 2 31311 Uetze / DE
	04 / LABUS, Josephine Stadtstraße 2 30159 Hannover / DE
	05 / DITYATEV, Alexander Bahnhofstrasse 37 39175 Wahlitz / DE
	06 / VARBANOV, Hristo Alfred-Delp-Str. 148 55122 Mainz / DE
	07 / JIA, Shaobo Leibniz Strasse 25 Raum 16 39104 Magdeburg / DE
	08 / SUN, Weilun Walther-Rathenau-Str.58/503 39104 Magdeburg / DE
	[2023/16]
Former [2021/31]	01 / PONIMASKIN, Evgeni Am Friedenstal 11A 30627 Hannover / DE
	02 / ROEHRS, Kian-Fritz Drei Eichen 19 27283 Verden/Aller / DE
	03 / BUTZLAFF, Malte Benrode 2 31311 Uetze / DE
	04 / LABUS, Josephine Stadtstraße 2 30159 Hannover / DE
	05 / DITYATEV, Alexander Bahnhofstrasse 37 39175 Wahlitz / DE
	06 / VARBANOV, Hristo Alfred-Delp-Str. 148 55122 Mainz / DE
	07 / JIA, Shaobo Leibniz Strasse 25 Raum 16 39104 Magdeburg / DE
	08 / WEILUN, Sun Walther-Rathenau-Str.58/503 39104 Magdeburg / DE
Representative(s)	Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB Ganghoferstraße 68 B 80339 München / DE
	[2021/31]
Application number, filing date	19790145.7	30.09.2019
	[2021/31]
	WO2019EP76397
Priority number, date	EP20180197401	28.09.2018 Original published format: EP 18197401
	[2021/31]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2020065090
	Date:	02.04.2020
	Language:	EN
	[2020/14]
	Type:	A2 Application without search report
	No.:	EP3856156
	Date:	04.08.2021
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.04.2020 takes the place of the publication of the European patent application.
	[2021/31]
Search report(s)	International search report - published on:	EP	07.05.2020
Classification	IPC:	A61K31/00, A61K31/40, A61K31/454, A61K31/495, A61K31/496, A61K31/55, A61K31/551, A61P25/16, A61P25/28	[2021/31]
	CPC:	A61K31/495 (EP,US); A61K31/40 (EP,US); A61K31/00 (EP); A61K31/166 (US); A61K31/454 (EP,US); A61K31/496 (EP,US); (+) A61K31/55 (EP,US); A61K31/551 (EP); A61K31/5513 (US); A61P25/16 (EP); A61P25/28 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/31]
Title	German:	5-HT7-ANTAGONIST ZUR BEHANDLUNG VON MIT DEMENZ ASSOZIIERTEN TAUOPATHIEN	[2021/31]
	English:	5-HT7 ANTAGONIST FOR THE TREATMENT OF DEMENTIA-ASSOCIATED TAUOPATHIES	[2021/31]
	French:	TRAITEMENT DE TAUOPATHIES ASSOCIÉES À UNE DÉMENCE	[2021/31]
Entry into regional phase	28.04.2021	National basic fee paid
	28.04.2021	Designation fee(s) paid
	28.04.2021	Examination fee paid
Examination procedure	28.04.2021	Examination requested [2021/31]
	28.04.2021	Date on which the examining division has become responsible
	17.11.2021	Amendment by applicant (claims and/or description)
	22.03.2024	Despatch of a communication from the examining division (Time limit: M06)
	23.09.2024	Reply to a communication from the examining division
Fees paid	Renewal fee
	28.04.2021	Renewal fee patent year 03
	27.09.2022	Renewal fee patent year 04
	26.09.2023	Renewal fee patent year 05
	25.09.2024	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]WO0037082 (SMITHKLINE BEECHAM PLC [GB], et al) [A] 1-9 * abstract *;
		[X]WO02062788 (SMITHKLINE BEECHAM PLC [GB], et al) [X] 1,2,5-9 * abstract * * page 1, line 1 - line 5 * * page 8, line 40 - page 9, line 13 * * examples 1,18; claim -; tables 1,2 *;
		[X]WO2013038200 (UNIV SUSSEX [GB], et al) [X] 1-9 * page 10, line 4 - line 18 * * claims 17,22,24 *;
		[X] - GASBARRI A ET AL, "Effect of 5-HT"7 antagonist SB-269970 in the modulation of working and reference memory in the rat", BEHAVIOURAL BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 195, no. 1, doi:10.1016/J.BBR.2007.12.020, ISSN 0166-4328, (20081216), pages 164 - 170, (20080109), XP025471553 [X] 1-9 * the whole document * DOI: http://dx.doi.org/10.1016/j.bbr.2007.12.020
		[X] - ALEXANDRE V. IVACHTCHENKO ET AL, "AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders", JOURNAL OF ALZHEIMER'S DISEASE, NL, (20160713), vol. 53, no. 2, doi:10.3233/JAD-151146, ISSN 1387-2877, pages 583 - 620, XP055568533 [X] 1,8,9 * abstract * * page 583, column l, paragraph l - page 584, column r, paragraph 2 * DOI: http://dx.doi.org/10.3233/JAD-151146
		[A] - MALTE BUTZLAFF ET AL., "The Role of Serotonin Receptors in Alzheimer's Disease", OPERA MEDICA ET PHYSIOLOGICA, (201601), vol. 2, no. 1, pages 77 - 86, XP002789898 [A] 1-9 * the whole document *
		[XP] - Kathrin Jahreis, Josephine Labus, Evgeni Ponimaskin, "The role of 5-HT7-receptor signalling in neurodegenerativediseases", (201903), page T11-12B, Göttingen Meeting of the German Neuroscience Society 2019, URL: https://www.nwg-goettingen.de/2019/upload/file/Proceedings-NWG-2019.pdf, (20190320), XP002789899 [XP] 1,7-9 * the whole document *
	by applicant	- ARENDT et al., Brain Res. Bull., (20160000), vol. 126, pages 238 - 292
		- JOSEPHS, Mayo Clin. Proc., (20170000), vol. 92, pages 1291 - 1303
		- WANGMANDELKOW, Nat. Rev. Neurosci., (20150000), vol. 17, pages 22 - 35
		- BUEE et al., Brain Res Brain Res Rev, (20000000), vol. 33, pages 95 - 130
		- STRAC et al., Transl Neurosci., (20160000), vol. 7, no. 1, pages 35 - 492
		- GOEDERT et al., The Neuroscientist., (19970000), vol. 3, pages 131 - 141
		- BRAAKBRAAK, Acta Neuropathologica, (19910000), vol. 82, pages 239 - 259
		- ARRIAGADA et al., Neurology, (19920000), vol. 42, no. 3, page 631
		- MAHE et al., Eur J Pharmacol, (20040000), vol. 495, no. 2-3, pages 97 - 102
		- THOMAS et al., British Journal of Pharmacology, (19980000), vol. 124, pages 1300 - 1306
		- STREJAN et al., J. Neuroimmunol., (19840000), vol. 7, page 27
		- HEDLUND et al., Trends Pharmacol. Sci., (20030000), vol. 25, pages 481 - 486
		- SPERANZA et al., Neuropharmacology, (20130000), vol. 67, pages 155 - 167
		- RENNER et al., J. Cell Sci., (20120000), vol. 125, pages 2486 - 2499
		- WLODARCZYK et al., Biophys. J., (20080000), vol. 94, pages 986 - 1000
		- BRENNAMAN et al., Neurobiology of Disease, (20110000), vol. 43, pages 372 - 378
		- GUSEVA et al., Brain, (20090000), vol. 132, pages 2180 - 95
		- NELSON et al., Behavioral neuroscience, (20110000), vol. 125, pages 396 - 403
		- TAK et al., "Bimolecular Fluorescence Complementation; Lighting-Up Tau-Tau Interaction in Living Cells 2013", PLOS ONE, (20130000), vol. 8, doi:doi:10.1371/journal.pone.0081682, XP055452308 DOI: http://dx.doi.org/10.1371/journal.pone.0081682
		- MACCIONI et al., Arch. Med. Res., (20010000), vol. 41, pages 226 - 231
		- HONG et al., Science, (19980000), vol. 282, page 1914
		- PEREZ et al., J. Neurochem., (20000000), vol. 74, pages 2583 - 2589
		- SAKAUE et al., J. Biol. Chem., (20050000), vol. 280, pages 31522 - 31529
		- KVACHNINA, J. Neurosci., (20050000), vol. 25, pages 7821 - 7830
		- SAYAS et al., J. Neurosci., (20020000), vol. 22, pages 6863 - 6875
		- LUND et al., Neurochem., (20010000), vol. 76, pages 1221 - 1232
		- LIU et al., Lett., (20020000), vol. 530, pages 209 - 214
		- NIKOLIC et al., Genes Dev., (19960000), vol. 10, pages 816 - 825
		- GREENBERGDAVIES, Proc. Natl. Acad. Sci., (19900000), vol. 87, pages 5827 - 5831
		- RENSAHARA, Front. Neurol., (20130000), vol. 4
		- BERGER et al., J. Neurosci., (20070000), vol. 27, pages 3650 - 3662
		- ROBERSON et al., Science, (20070000), vol. 316, pages 750 - 754
		- GARETH et al., J. Neuro., (20070000), vol. 27, no. 11, pages 2948 - 2957
		- TAK et al., "Bimolecular Fluorescence Complementation; Lighting-Up Tau-Tau Interaction in Living Cells 2013", PLOS ONE, vol. 8

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p